Early rehabilitation program for liver transplantation
BehavioralDeliver the one of 5-step early rehabilitation program for immediate liver transplant pts on weekday
NCT Number: NCT03529656
The purpose of this study is to determine whether an early rehabilitation program for immediate liver transplant patients is safe and effective in preventing critical care illness and intensive care unit acquired weakness.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Patients with liver transplantation (LT) have poor general condition before surgery and require ICU care for a certain period. For those patients, the side effects of ICU care such as intensive care unit-acquired weakness (ICU-AW), critical illness polyneuropathy (CIP) are well known. Therefore, we access the safety and efficacy of early rehabilitation program (ERP) in liver transplant recipients.
Patients were retrospectively selected for the Pre-ERP group (2014.05-2014.10) and for the Post-ERP group (2015.10-2016.03). During the period of 6 months, 136 patients and 100 patients underwent LT, and 65, 62 patients were enrolled after exclusion. Forty patients from the each group were compared after propensity score matching (PSM).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Deliver the one of 5-step early rehabilitation program for immediate liver transplant pts on weekday
Time frame: up to 60 days
Time frame: up to 60 days
Time frame: up to 2 weeks
Time frame: up to 24 weeks
Time frame: 1 year follow up from the surgery
Time frame: 1 year follow up from the surgery
Asan Medical Center
Other
The Safety and Efficacy of Early Rehabilitation Program in Immediate Liver Transplant Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07677488
Agnosia, Critical Illness
Suzhou, Jiangsu, China
View Trial DetailsNCT06944431
Atrophy, Critical Illness
Taipei, Taiwan
View Trial DetailsNCT03055949
ICU-acquired Weakness
View Trial DetailsNCT07362862
Atrophy, Critical Illness
Rochester, Minnesota, United States
View Trial Details